SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI)
CRIS 1.120-4.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SDR-SI who wrote (148)5/18/1998 12:11:00 PM
From: Larry Liebman  Read Replies (1) of 668
 
I've been far more successful picking out companies at "depressed" levels than chasing the "hot" selections of the day. That being said, I have a stake in CBMI which has slowly decayed from the $10 level. I spoke with Carla M.(Investor Relations). Her take:
(a) Stryker submitted the first part of the PMA for bone-grafts with OP-1. Will complete the rest by mid-year.
(b) Stryker is in trials in a number of OP-1 indications. Stryker was described as "not wanting to disclose its cards" to competitors.
(c) Biogen is expected to announce its indication for a renal program by mid-year.
(d) Significant progress is being made in the neurology arena. The company is deciding whether to partner this indication or move it through trials by itself. Resources will determine the decision.
I could absolutely be wrong, but this looks like a good time to purchase a stake.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext